Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Menendez

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Blood|April 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapiesClara Bueno, Susana Barrera, Alex Bataller, et al.
Nature Communications|October 8, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemiaLouise Ahlgren, Mattias Pilheden, Helena Sturesson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia, Colin Ockleford, Paulien Adriaanse, et al.
Blood|June 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumabAlba Rubio-Gayarre, Meritxell Vinyoles, Juan Ramón Tejedor, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Blood|August 2, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expressionBelén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles, et al.
Nature Cell Biology|August 21, 2024
RNA sequestration in P-bodies sustains myeloid leukaemiaSrikanth Kodali, Ludovica Proietti, Gemma Valcarcel, et al.
Blood|March 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemiaAïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Blood|April 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapiesClara Bueno, Susana Barrera, Alex Bataller, et al.
Nature Communications|October 8, 2025
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemiaLouise Ahlgren, Mattias Pilheden, Helena Sturesson, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia, Colin Ockleford, Paulien Adriaanse, et al.
Blood|June 25, 2026
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumabAlba Rubio-Gayarre, Meritxell Vinyoles, Juan Ramón Tejedor, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Blood|August 2, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expressionBelén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles, et al.
Nature Cell Biology|August 21, 2024
RNA sequestration in P-bodies sustains myeloid leukaemiaSrikanth Kodali, Ludovica Proietti, Gemma Valcarcel, et al.
Blood|March 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemiaAïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti, et al.
Pageof 13